Corporate Profile
WuXi PharmaTech (pronounced woo-shee pharma-tek) is a leading global contract R&D services provider serving the pharmaceutical, biotech, and medical device industries. The company is headquartered in Shanghai and has operations in both China and the United States. We provide a broad and integrated portfolio of laboratory and manufacturing services throughout the R&D process. Our services are designed to help our global partners shorten the time and lower the cost of R&D. The parent company is known as WuXi PharmaTech, and its operating divisions are known as WuXi AppTec (pronounced woo-shee app-tek)... More >>
What's New
download pdf  Investor Fact Sheet
Recent NewsMore >>
DateTitle 
11/12/14WuXi PharmaTech Announces Third-Quarter 2014 Results
SHANGHAI, Nov. 12, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial results for the third quarter of 2014. Third-Quarter 2014 Highlights Net Revenues Increased 18.3% Year Over Year to $173.6 Million Laboratory Services Net Revenues Grew 16.6% Year Ove... 
Printer Friendly Version
11/12/14WuXi AppTec Announces Enhanced Genomics Services for Chinese Researchers
SHANGHAI, Nov. 12, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced an enhancement to its genomics services. The WuXi Genome Center will provide Chinese researchers who use its gene sequencing services with access to the integrated sequence analysis capabilities of NextCODE ... 
Printer Friendly Version
11/11/14WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2014 Annual General Meeting
SHANGHAI, Nov. 11, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) today announced shareholder resolutions adopted at its annual general meeting of shareholders held in Hong Kong on November 11, 2014. At the meeting, WuXi PharmaTech shareholders approved the re-election of incumbent Class A directors Xiaozhong Liu, Kian Wee Seah, and William R. Keller, each to serve a three-year term. About WuXi PharmaTech WuXi PharmaTech is a leading open-access R&D capability and tec... 
Printer Friendly Version
10/30/14WuXi AppTec Launches Representative Office in Israel, Forms Strategic Collaboration with Pontifax
SHANGHAI, Oct. 30, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced the establishment of a representative office in the Tel Aviv area of Israel.  The new office will promote WuXi's broad platform of integrated R&D services to local customers. It will also collaborate ... 
Printer Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
Stock QuoteMore >>
WX (Common Stock)
ExchangeNYSE (US Dollar)
Price$34.31
Change (%) Stock is Down 0.08 (0.23%)
Volume101,517
Data as of 11/28/14 1:02 p.m. ET
Minimum 20 minute delay
Refresh quote
CalendarMore >>
November 2014?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SunMonTueWedThuFriSat
-6-5-4-3-2-11
2345678
9101112131415
16171819202122
23242526272829
30515253545556
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever WuXi PharmaTech (Cayman) Inc. posts new information to the site. Just enter your e-mail address and click Submit.
 

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.